+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Tablets, Capsules, Powders, Granules), Mechanism, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 5626281
Description Jump to:
The global oral solid dosage contract manufacturing market is expected to reach USD 54.7 billion by 2030 and expand at a CAGR of 5.97% from 2024 to 2030. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth.

Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential.

Technological advancements in the development and bulk manufacturing of oral solid dosage forms are among the primary factors supporting the fast-track commercialization of these products. Currently, a diverse array of dosage forms is accessible in the market. However, the nutraceutical and pharmaceutical industries consistently put effort into developing OSD forms. This preference is due to their ease of handling, convenient consumption, and positive patient adherence. Anticipated advancements in technology and materials of OSD forms are projected to boost the demand for these formulations.

Furthermore, R&D investments by CMOs and CDMOs contribute to enhanced innovation in manufacturing processes, formulation development, & analytical technologies. This can lead to the adoption of more efficient and advanced manufacturing techniques in the production of oral solid dosage forms. Also, investments in R&D result in the expansion of manufacturing capabilities and improved scalability. This allows CMOs and CDMOs to offer larger volumes of oral solid dosage production to meet the increasing demand from pharmaceutical companies.

Moreover, the industry witnessed many strategic movements in 2023, such as collaborations, partnerships, M&As, service expansion, etc.
  • In July 2023, Aenova Group and Galvita entered a strategic partnership to improve the formulation, production, and development of oral dosage forms.
  • In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity.
  • In January 2023, Catalent and Ethicann collaborated to develop Ethicann’s clinical drug pipeline using Catalent’s technology known as Orally Disintegrating Tablet (ODT) technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights

  • The tablets segment dominated the market with a revenue share of 32.7% in 2023. Tablets are the most common and preferred OSD form due to their cost-effectiveness, high compactness, easy manufacturing, and convenience of self-administration. Increased demand for bilayer tablets and investments by firms to expand formulation and controlled-release tablet manufacturing are predicted to drive market growth
  • The controlled release segment accounted for the largest share of 52.2% in 2023. This growth is attributed to advancements in oral controlled release delivery systems, including dome tablets, dual drug tablets, intestinal patches, polymer nanosystems, and bioinspired delivery methods, such as exosomes for precise drug delivery. Thus, high demand for control release dosage forms is anticipated to boost segmental revenue growth in the near future
  • Based on end-use, the large size companies segment accounted for the largest share of 54.8% in 2023. The solid dose manufacturing market is increasingly defined by collaboration, flexibility, and high adaptability. More pharma developers design drugs from the start, intending to outsource them to large CMOs, thereby accelerating market growth. Furthermore, CMOs specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption
  • Asia-Pacific led the global market in 2023 and is projected to witness the fastest CAGR of 6.3% during the forecast years. China and India are the powerhouses of oral solid dosage contract manufacturing organizations with significantly lower prices. Further, expanding manufacturing capabilities among Asian countries such as Singapore, India, and South Korea have been considered major players in the pharmaceutical industry due to their expanding manufacturing capabilities

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.5.1 Region Wise Market Calculation
1.5.2 Region Wise Market: Base Estimates
1.5.3 Global Market: Cagr Calculation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Value-Chain-Based Sizing & Forecasting (Model 2)
1.6.3 Qfd Model Sizing & Forecasting (Model 3)
1.7 Market Formulation & Validation
1.8 Market Definitions/Scope
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 List Of Abbreviations
1.12 Objectives
1.12.1 Objective - 1
1.12.2 Objective - 2
1.12.3 Objective - 3
1.12.4 Objective - 4
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Oral Solid Dosage Contract Manufacturing Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Technological Advancements In Oral Solid Dosage (Osd) Forms
3.2.1.2 Expansion Of Manufacturing Capacity By Cmos & Cdmos For Osd
3.2.1.3 Increasing Demand For Novel Therapies
3.2.1.4 Increasing Demand For One-Stop-Shop Cdmos
3.2.2 Market Restraint Analysis
3.2.2.1 Strict Approval Criteria By Regulatory Authorities
3.2.2.2 Lack Of Experienced Technical Staff, Physical Capability, And Equipment Capacity
3.2.2.3 Increasing Need For Biosimilars And Their Prominence In Addressing Cancer & Other Medical Conditions
3.3 Oral Solid Dosage Contract Manufacturing Market: Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestel Analysis
3.4 Covid-19 Impact Analysis
3.5 Analysis Pertaining To Oral Solid Dosage Packaging Types, by Blisters Vs. Bottles (Volume % Share, 2022)
3.5.1 Blister Packaging
3.5.2 Bottle Packaging
3.5.3 Types Of Blister Packaging
3.5.4 Blister Packaging
Chapter 4 Oral Solid Dosage Contract Manufacturing Market: Segment Analysis, by Product Type, 2018-2030 (USD Million)
4.1 Oral Solid Dosage Contract Manufacturing Market By Product Type: Key Takeaways
4.2 Oral Solid Dosage Contract Manufacturing Market: Product Type Movement Analysis
4.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By Product Type (USD Million)
4.3.1 Tablets
4.3.1.1 Tablets Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (USD Million)
4.3.2 Capsules
4.3.2.1 Capsules Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (USD Million)
4.3.3 Powders
4.3.3.1 Powders Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (USD Million)
4.3.4 Granules
4.3.4.1 Granules Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (USD Million)
4.3.5 Others
4.3.5.1 Others Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (USD Million)
Chapter 5 Oral Solid Dosage Contract Manufacturing Market: Mechanism Analysis
5.1 Oral Solid Dosage Contract Manufacturing Market By Mechanism Segment: Key Takeaways
5.2 Oral Solid Dosage Contract Manufacturing Market: Mechanism Movement Analysis
5.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By Mechanism (USD Million)
5.3.1 Immediate Release (IR)
5.3.1.1 Immediate Release Contract Manufacturing Market, 2018-2030 (USD Million)
5.3.2 Delayed Release
5.3.2.1 Delayed Release Contract Manufacturing Market, 2018-2030 (USD Million)
5.3.3 Controlled Release (CR)
5.3.3.1 Controlled Release Contract Manufacturing Market, 2018-2030 (USD Million)
Chapter 6 Oral Solid Dosage Contract Manufacturing Market: End-Use Analysis
6.1 Oral Solid Dosage Contract Manufacturing Market, by End-Use Segment: Key Takeaways
6.2 Oral Solid Dosage Contract Manufacturing Market: End-Use Movement Analysis
6.3 Oral Solid Dosage Contract Manufacturing Market Estimates & Forecasts By End-Use (USD Million)
6.3.1 Large-Size Companies
6.3.1.1 Large-Size Companies Contract Manufacturing Market, 2018-2030 (USD Million)
6.3.2 Medium- & Small-Size Companies
6.3.2.1 Medium- & Small- Sized Companies Contract Manufacturing Market, 2018-2030 (USD Million)
6.3.3 Others
6.3.3.1 Others Contract Manufacturing Market, 2018-2030 (USD Million)
Chapter 7 Oral Solid Dosage Contract Manufacturing Market: Regional Analysis
7.1 Oral Solid Dosage Contract Manufacturing: Market Share Analysis, 2023 & 2030
7.2 Oral Solid Dosage Contract Manufacturing: Market Estimates And Forecasts, by Region (USD Million)
7.3 North America
7.3.1 North America Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (USD Million)
7.3.2 U.S.
7.3.2.1 Key Country Dynamics
7.3.2.2 Competitive Scenario
7.3.2.3 Regulatory Scenario
7.3.2.4 U.S. Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.3 Canada
7.3.3.1 Key Country Dynamics
7.3.3.2 Competitive Scenario
7.3.3.3 Regulatory Scenario
7.3.3.4 Canada Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4 Europe
7.4.1 Europe Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (USD Million)
7.4.2 Uk
7.4.2.1 Key Country Dynamics
7.4.2.2 Competitive Scenario
7.4.2.3 Regulatory Scenario
7.4.2.4 Uk Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.3 Germany
7.4.3.1 Key Country Dynamics
7.4.3.2 Competitive Scenario
7.4.3.3 Regulatory Scenario
7.4.3.4 Germany Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.4 France
7.4.4.1 Key Country Dynamics
7.4.4.2 Competitive Scenario
7.4.4.3 Regulatory Scenario
7.4.4.4 France Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.5 Italy
7.4.5.1 Key Country Dynamics
7.4.5.2 Competitive Scenario
7.4.5.3 Regulatory Scenario
7.4.5.4 Italy Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.6 Spain
7.4.6.1 Key Country Dynamics
7.4.6.2 Competitive Scenario
7.4.6.3 Regulatory Scenario
7.4.6.4 Spain Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.7 Denmark
7.4.7.1 Key Country Dynamics
7.4.7.2 Competitive Scenario
7.4.7.3 Regulatory Scenario
7.4.7.4 Denmark Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030, (USD Million)
7.4.8 Sweden
7.4.8.1 Key Country Dynamics
7.4.8.2 Competitive Scenario
7.4.8.3 Regulatory Scenario
7.4.8.4 Sweden Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030, (USD Million)
7.4.9 Norway
7.4.9.1 Key Country Dynamics
7.4.9.2 Competitive Scenario
7.4.9.3 Regulatory Scenario
7.4.9.4 Norway Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030, (USD Million)
7.5 Asia-Pacific
7.5.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, 2018-2030 (USD Million
7.5.2 China
7.5.2.1 Key Country Dynamics
7.5.2.2 Competitive Scenario
7.5.2.3 Regulatory Scenario
7.5.2.4 China Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.3 India
7.5.3.1 Key Country Dynamics
7.5.3.2 Competitive Scenario
7.5.3.3 Regulatory Scenario
7.5.3.4 India Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.4 Japan
7.5.4.1 Key Country Dynamics
7.5.4.2 Competitive Scenario
7.5.4.3 Regulatory Scenario
7.5.4.4 Japan Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.5 Australia
7.5.5.1 Key Country Dynamics
7.5.5.2 Competitive Scenario
7.5.5.3 Regulatory Scenario
7.5.5.4 Australia Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.6 South Korea
7.5.6.1 Key Country Dynamics
7.5.6.2 Competitive Scenario
7.5.6.3 Regulatory Scenario
7.5.6.4 South Korea Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.7 Thailand
7.5.7.1 Key Country Dynamics
7.5.7.2 Competitive Scenario
7.5.7.3 Regulatory Scenario
7.5.7.4 Thailand Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6 Latin America
7.6.1 Latin America Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.2 Brazil
7.6.2.1 Key Country Dynamics
7.6.2.2 Competitive Scenario
7.6.2.3 Regulatory Scenario
7.6.2.4 Brazil Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.3 Mexico
7.6.3.1 Key Country Dynamics
7.6.3.2 Competitive Scenario
7.6.3.3 Regulatory Scenario
7.6.3.4 Mexico Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.4 Argentina
7.6.4.1 Key Country Dynamics
7.6.4.2 Competitive Scenario
7.6.4.3 Regulatory Scenario
7.6.4.4 Argentina Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030, (USD Million)
7.7 MEA
7.7.1 MEA Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030, (USD Million)
7.7.2 South Africa
7.7.2.1 Key Country Dynamics
7.7.2.2 Competitive Scenario
7.7.2.3 Regulatory Scenario
7.7.2.4 South Africa Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030, (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Key Country Dynamics
7.7.3.2 Competitive Scenario
7.7.3.3 Regulatory Scenario
7.7.3.4 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030, (USD Million)
7.7.4 UAE
7.7.4.1 Key Country Dynamics
7.7.4.2 Competitive Scenario
7.7.4.3 Regulatory Scenario
7.7.4.4 UAE Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
7.7.5 Kuwait
7.7.5.1 Key Country Dynamics
7.7.5.2 Competitive Scenario
7.7.5.3 Regulatory Scenario
7.7.5.4 Kuwait Oral Solid Dosage Contract Manufacturing Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 8 Competitive Landscape
8.1. Company Landscape
8.1.1. Richter-Helm BioLogics
8.1.1.1. Company overview
8.1.1.2. Financial performance
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. Lonza
8.1.2.1. Company overview
8.1.2.2. Financial performance
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. Catalent, Inc
8.1.3.1. Company overview
8.1.3.2. Financial performance
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Lonza
8.1.4.1. Company overview
8.1.4.2. Financial performance
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Aenova Group
8.1.5.1. Company overview
8.1.5.2. Financial performance
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Boehringer Ingelheim International GmbH
8.1.6.1. Company overview
8.1.6.2. Financial performance
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Jubilant Pharmova Limited
8.1.7.1. Company overview
8.1.7.2. Financial performance
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. Patheon Pharma Services
8.1.8.1. Company overview
8.1.8.2. Financial performance
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Recipharm AB.
8.1.9.1. Company overview
8.1.9.2. Financial performance
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
8.1.10. Corden Pharma International
8.1.10.1. Company overview
8.1.10.2. Financial performance
8.1.10.3. Product benchmarking
8.1.10.4. Strategic initiatives
8.1.11. Siegfried Holding AG
8.1.11.1. Company overview
8.1.11.2. Financial performance
8.1.11.3. Product benchmarking
8.1.11.4. Strategic initiatives
8.1.12. Piramal Pharma Solutions
8.1.12.1. Company overview
8.1.12.2. Financial performance
8.1.12.3. Product benchmarking
8.1.12.4. Strategic initiatives
8.1.13. AbbVie Contract Manufacturing
8.1.13.1. Company overview
8.1.13.2. Financial performance
8.1.13.3. Product benchmarking
8.1.13.4. Strategic initiatives
8.1.14. Next Pharma AB
8.1.14.1. Company overview
8.1.14.2. Financial performance
8.1.14.3. Product benchmarking
8.1.14.4. Strategic initiatives
8.2 Company Categorization
8.3 Product/Service Heat Map Analysis
8.4 Strategy Initiatives
8.4.1 Acquisition
8.4.2 Collaboration
8.4.3 Expansion
8.4.4 Service Launch
8.4.5 Partnership
8.4.6 Others
Chapter 9 Key Takeaways
List of Tables
Table 1 List of abbreviation
Table 2 North America Oral Solid Dosage Contract Manufacturing market, by region, 2018-2030 (USD Million)
Table 3 North America Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 4 North America Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 5 North America Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 6 U.S. Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 7 U.S. Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 8 U.S. Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 9 Canada Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 10 Canada Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 11 Canada Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 12 Europe Oral Solid Dosage Contract Manufacturing market, by region, 2018-2030 (USD Million)
Table 13 Europe Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 14 Europe Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 15 Europe Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 16 UK Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 17 UK Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 18 UK Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 19 Germany Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 20 Germany Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 21 Germany Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 22 France Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 23 France Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 24 France Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 25 Italy Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 26 Italy Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 27 Italy Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 28 Spain Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 29 Spain Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 30 Spain Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 31 Denmark Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 32 Denmark Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 33 Denmark Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 34 Sweden Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 35 Sweden Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 36 Sweden Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 37 Norway Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 38 Norway Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 39 Norway Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 40 Asia-Pacific Oral Solid Dosage Contract Manufacturing market, by region, 2018-2030 (USD Million)
Table 41 Asia-Pacific Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 42 Asia-Pacific Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 43 Asia-Pacific Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 44 China Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 45 China Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 46 China Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 47 India Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 48 India Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 49 India Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 50 Japan Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million) 2018-2030
Table 51 Japan Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 52 Japan Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 53 Australia Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 54 Australia Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 55 Australia Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 56 South Korea Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 57 South Korea Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 58 South Korea Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 59 Thailand Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 60 Thailand Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 61 Thailand Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 62 Latin America Oral Solid Dosage Contract Manufacturing market, by region, 2018-2030 (USD Million)
Table 63 Latin America Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 64 Latin America Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 65 Latin America Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 66 Brazil Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million) 2018-2030
Table 67 Brazil Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 68 Brazil Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 69 Mexico Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 70 Mexico Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 71 Mexico Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 72 Argentina Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 73 Argentina Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 74 Argentina Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 75 MEA Oral Solid Dosage Contract Manufacturing market, by region, 2018-2030 (USD Million)
Table 76 MEA Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 77 MEA Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 78 MEA Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 79 South Africa Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 80 South Africa Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 81 South Africa Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 82 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 84 Saudi Arabia Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 85 UAE Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 86 UAE Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 87 UAE Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
Table 88 Kuwait Oral Solid Dosage Contract Manufacturing market, by product type, 2018-2030 (USD Million)
Table 89 Kuwait Oral Solid Dosage Contract Manufacturing market, by mechanism, 2018-2030 (USD Million)
Table 90 Kuwait Oral Solid Dosage Contract Manufacturing market, by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Oral solid dosage contract manufacturing market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-Chain-Based Sizing & Forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Market formulation & validation
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market outlook, 2023 (USD Million)
Fig. 16 Ancillary market outlook, 2023 (USD Million)
Fig. 17 Oral solid dosage contract manufacturing market dynamics
Fig. 18 Biosimilar approval in the U.S. and EU per year (2016-2021)
Fig. 19 Porter’s five forces analysis
Fig. 20 PESTEL analysis
Fig. 21 Oral solid dosage packaging types in the U.S., 2023 (volume percentage share %)
Fig. 22 Oral solid dosage blister packaging types in the U.S., 2023 (volume percentage share %)
Fig. 23 Oral solid dosage contract manufacturing market: Product type outlook and key takeaways
Fig. 24 Oral solid dosage contract manufacturing market: Product type movement analysis
Fig. 25 Tablets oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD million)
Fig. 26 Capsules oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD million)
Fig. 27 Powders oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD million)
Fig. 28 Granules oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD million)
Fig. 29 Others oral solid dosage contract manufacturing market estimates and forecasts, 2018-2030 (USD million)
Fig. 30 Oral solid dosage contract manufacturing market: Mechanism outlook and key takeaways
Fig. 31 Oral solid dosage contract manufacturing market: Mechanism movement analysis
Fig. 32 Immediate release contract manufacturing market estimates and forecasts, 2018-2030 (USD million)
Fig. 33 Delayed release contract manufacturing market estimates and forecasts, 2018-2030 (USD million)
Fig. 34 Controlled release contract manufacturing market estimates and forecasts, 2018-2030 (USD million)
Fig. 35 Oral solid dosage contract manufacturing market: End-use outlook and key takeaways
Fig. 36 Oral solid dosage contract manufacturing market: End-use movement analysis
Fig. 37 Large-size companies market estimates and forecasts, 2018-2030 (USD million)
Fig. 38 Medium- & small- sized companies market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Others market estimates and forecast, 2018-2030 (USD million)
Fig. 40 Regional market: Key takeaways
Fig. 41 Regional outlook, 2023 & 2030
Fig. 42 Regional outlook, 2023 & 2030
Fig. 43 North America market, 2018-2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 U.S. Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 Canada Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Europe Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 UK Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Germany Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 France Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Italy Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Spain Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Denmark Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Sweden Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Norway Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 65 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 China Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Regulatory bodies in India involved in pharmaceutical regulations
Fig. 70 India Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Clinical trial authorization process in Japan
Fig. 73 Clinical Research of Medical Products in Japan
Fig. 74 Japan Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 78 Australia Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 Clinical trial approval process in South Korea
Fig. 81 South Korea Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Thailand Oral Solid Dosage Contract Manufacturing Market estimates and forecasts, 2018-2030 (USD Million)
Fig. 84 Latin America Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Brazil Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Mexico Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Argentina Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 91 MEA Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 South Africa Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Saudi Arabia Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Clinical trial authorization process UAE
Fig. 98 UAE Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Kuwait Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 101 Key company categorization
Fig. 102 Product/service heat map analysis

Companies Mentioned

  • Richter-Helm BioLogics
  • Lonza
  • Catalent, Inc
  • Lonza
  • Aenova Group
  • Boehringer Ingelheim International GmbH
  • Jubilant Pharmova Limited
  • Patheon Pharma Services
  • Recipharm AB.
  • Corden Pharma International
  • Siegfried Holding AG
  • Piramal Pharma Solutions
  • AbbVie Contract Manufacturing
  • Next Pharma AB

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 36.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 54.7 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market by Product, Mechanism, End-User - Global Forecast 2025-2030 - Product Image

Oral Solid Dosage Contract Manufacturing Market by Product, Mechanism, End-User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030 - Product Image

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Market by Product Type, by Mechanism, by End-User, and By Region - Product Image

Oral Solid Dosage Contract Manufacturing Market by Product Type, by Mechanism, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Oral Solid Dosage Contract Manufacturing Global Market Report 2024 - Product Image

Oral Solid Dosage Contract Manufacturing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.